Bell Richard L, Hauser Sheketha R, McClintick Jeanette, Rahman Shafiqur, Edenberg Howard J, Szumlinski Karen K, McBride William J
Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Prog Mol Biol Transl Sci. 2016;137:41-85. doi: 10.1016/bs.pmbts.2015.10.018. Epub 2015 Nov 24.
Herein, we have reviewed the role of glutamate, the major excitatory neurotransmitter in the brain, in a number of neurochemical, -physiological, and -behavioral processes mediating the development of alcohol dependence. The findings discussed include results from both preclinical as well as neuroimaging and postmortem clinical studies. Expression levels for a number of glutamate-associated genes and/or proteins are modulated by alcohol abuse and dependence. These changes in expression include metabotropic receptors and ionotropic receptor subunits as well as different glutamate transporters. Moreover, these changes in gene expression parallel the pharmacologic manipulation of these same receptors and transporters. Some of these gene expression changes may have predated alcohol abuse and dependence because a number of glutamate-associated polymorphisms are related to a genetic predisposition to develop alcohol dependence. Other glutamate-associated polymorphisms are linked to age at the onset of alcohol-dependence and initial level of response/sensitivity to alcohol. Finally, findings of innate and/or ethanol-induced glutamate-associated gene expression differences/changes observed in a genetic animal model of alcoholism, the P rat, are summarized. Overall, the existing literature indicates that changes in glutamate receptors, transporters, enzymes, and scaffolding proteins are crucial for the development of alcohol dependence and there is a substantial genetic component to these effects. This indicates that continued research into the genetic underpinnings of these glutamate-associated effects will provide important novel molecular targets for treating alcohol abuse and dependence.
在此,我们回顾了大脑中主要的兴奋性神经递质谷氨酸在介导酒精依赖发展的一系列神经化学、神经生理和行为过程中的作用。所讨论的研究结果包括临床前研究以及神经影像学和尸检临床研究的结果。多种与谷氨酸相关的基因和/或蛋白质的表达水平会受到酒精滥用和依赖的调节。这些表达变化包括代谢型受体和离子型受体亚基以及不同的谷氨酸转运体。此外,这些基因表达的变化与对这些相同受体和转运体的药物操作情况相似。这些基因表达变化中的一些可能在酒精滥用和依赖之前就已出现,因为一些与谷氨酸相关的多态性与酒精依赖的遗传易感性有关。其他与谷氨酸相关的多态性则与酒精依赖开始的年龄以及对酒精的初始反应/敏感性水平有关。最后,总结了在酒精中毒的遗传动物模型P大鼠中观察到的先天和/或乙醇诱导的与谷氨酸相关的基因表达差异/变化的研究结果。总体而言,现有文献表明谷氨酸受体、转运体、酶和支架蛋白的变化对酒精依赖的发展至关重要,并且这些影响存在大量的遗传成分。这表明对这些与谷氨酸相关的影响的遗传基础进行持续研究将为治疗酒精滥用和依赖提供重要的新分子靶点。